Gradientech AB

📍 Uppsala, Sweden🗓 Founded 2009👥 42 employees💰 Last funded Dec 2018
Gradientech is a Swedish biotech and diagnostics company dedicated to support the modern microbiology lab with state-of-the-art solutions to facilitate the workflow with time-critical samples. Our product QuickMIC® is an ultra-rapid system for antibiotic susceptibility testing (AST) of positive blood culture samples from sepsis patients. QuickMIC® is a scalable system with each instrument module analysing one sample against multiple antibiotics, well-suited for small and larger clinical laboratories. MIC values are reported in as short as 2 hours, making it more rapid than any other diagnostic system for phenotypic AST on the market. Gradientech’s technology combines microfluidics with live cell imaging to study cell responses in a linear concentration gradient. Our technology is a perfect match for many biological applications. Gradientech holds an ISO13485 certification.
3
Total investors
0
Early stage
2
Mid stage
1
Late stage
2009
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Late stage· 1
?
Member of the Board (adjunct)
late stage
Dec 2018
Investor geography1 country
Sweden
1
Investor activity2013–2018 · investors recorded per year
201312014120181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Gradientech AB?
Gradientech AB has 3 investors on record on gritt.io, 2 mid-stage and 1 late-stage investors.
When did Gradientech AB last raise funding?
The most recent investment in Gradientech AB recorded on gritt.io was in December 2018.
When was Gradientech AB founded?
Gradientech AB was founded in 2009.
What industry is Gradientech AB in?
Gradientech AB operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Gradientech AB based?
Gradientech AB is headquartered in Uppsala, Sweden.